Development and distribution of generic, biosimilar, and specialty pharmaceuticals with a focus on affordable healthcare access.
A
CSR Analysis score
The organization is among the top 5% of organizations with the most committed CSR positioning, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: May 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
Teva
B
Development, production, and marketing of generic drugs, biosimilars, and innovative medicines.
Viatris
A
Development and commercialization of generic, established brand, and innovative medicines across various therapeutic areas.
STADA Group
B
Manufacturing and distribution of high-quality pharmaceuticals, including consumer healthcare products, generics, and specialty medicines.
Initiatives identified among leaders
Obtention de certifications environnementales
“STADA Group a obtenu plusieurs certifications envi...” - STADA GroupProcédures strictes pour marketing et promotion éthique des médicaments.
“Mise en place de procédures globales, régionales e...” - ViatrisRéduction des émissions GES et transition vers 100% d'électricité renouvelable d'ici 2045
“Teva s'est engagé à réduire ses émissions de gaz à...” - Teva62% of similar organizations communicate on CSR issues
+607 initiatives collected from 47 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports